PepMLM generates binders to challenging therapeutic targets across cancer and neurological disease using protein sequence and ...

Schrödinger has halted development of its cancer-fighting candidate SGR-2921 after two patients treated with the CDC7 inhibitor died in a Phase I trial.

Researchers demonstrate that an engineered antibody improves a class of drugs that has struggled to make good on its early promise.

Peptidoglycan hydrolases killed living bacteria, opening the door for further research into the interplay between archaea and bacteria.

Researchers say work lays the foundation for a first-line, deployable antiviral platform that is virus agnostic and modular.

Antimicrobial resistance studies often focus on individual protein variants, neglecting broader protein family dynamics. Dihydrofolate reductase (DHFR), a key antibiotic target, has been extensively ...

The current $195 million investment is part of a commitment to invest more than $10 billion for innovation and manufacturing capacity enhancement.

Model serves as platform for understanding how chronic inflammation related to alcohol consumption accelerates pancreatic cancer development.

The basal ganglia in rats uses separate codes for learned movements and “natural” behaviors, offering insights into human ...

Sarepta Therapeutics said Friday that the deaths of two patients taking its marketed gene therapy Elevidys® (delandistrogene ...

AIs are as much a tool as a hammer or shovel, but to find the opportunities, we need to understand what the realities and risks are.

Researchers say the new concept that lithium deficiency could be a cause of Alzheimer’s disease points to a different ...